Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


Regulatory News


Director/PDMR Shareholding

Fri, 10th Nov 2017 15:57


RNS Number : 2242W
QinetiQ Group plc
10 November 2017

QinetiQ Group plc (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

(a)

Name

Steve Wadey

2.

Reason for the notification

(a)

Position / status

Chief Executive Officer/Director

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

QinetiQ Group plc

(b)

Legal Entity Identifier Code

213800S8OBDOZMCMUW34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Identification code

QinetiQ Group plc ordinary shares of 1 pence

GB00B0WMWD03

(b)

Nature of the transaction

Purchase of shares under the QinetiQ Share Incentive Plan

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.3575

85

(d)

Aggregated information

- Price

- Volume

- Total

2.3575

85

200.39

(e)

Date of the transaction

2017-11-09

(f)

Place of the transaction

London Stock Exchange - XLON


This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFLFISFWSEIF


Related Shares:
QinetiQ Group (QQ.)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.